Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of business
Generic drugs are the singularity of American healthcare – they are too cheap. And it’s driving some manufacturers out of business altogether.
Drug prices regularly sparks recrimination and outrage on Capitol Hill, such as a recently announced investigation by Senate Democrats and Bernie Sanders into the price of albuterol inhalers.
More Stories
Revealed: Chinese researchers can access half a million UK GP records
Brisk walking linked to lower risk of heart rhythm problems, study finds
RFK Jr contradicts experts by linking autism rise to ‘environmental toxins’